Alexander Chernyavskiy

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Gérald Simonneau, Andrea Maria D’Armini, Peter F. Fedullo et al. · The Lancet Respiratory Medicine · 2017 · 264 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia

Harmony R. Reynolds, Leslee J. Shaw, James K. Min et al. · JAMA Cardiology · 2020 · 156 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Judith S. Hochman, Harmony R. Reynolds, Sripal Bangalore et al. · JAMA Cardiology · 2019 · 132 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction

Renato D. Lópes, Karen P. Alexander, Susanna R. Stevens et al. · Circulation · 2020 · 121 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Gérald Simonneau, Andrea Maria D’Armini, Peter F. Fedullo et al. · The Lancet Respiratory Medicine · 2024 · 36 citations

Medicine, Internal Medicine, Pharmacotherapy +11